Collectively, these findings demonstrate that circFAM13B acts as an oncogene in the development of HCC, and circFAM13B function as a ceRNA by competitively binding to miR-212, upregulates expression of E2F5, inhibits the p53 signalling pathway, and promotes the proliferation of HCC. Here, E2F5 is linked to hepatocellular carcinoma.